• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫颈浸润性鳞状细胞癌放射治疗患者的癌胚抗原

Carcinoembryonic antigen in patients treated with radiation therapy for invasive squamous cell carcinoma of the uterine cervix.

作者信息

Donaldson E, Van Nagell J R, Wood E G, Pletsch Q, Goldenberg D M

出版信息

AJR Am J Roentgenol. 1976 Nov;127(5):829-31. doi: 10.2214/ajr.127.5.829.

DOI:10.2214/ajr.127.5.829
PMID:987709
Abstract

Plasma carcinoembryonic antigen (CEA) levels in 75 patients with invasive cervical cancer were measured during and after radiation therapy. Initial CEA levels were elevated in 65% of the patients, the incidence varying with stage of disease. Of the 32 patients followed during therapy, CEA levels rose in 26 (81%). CEA values after therapy in the same 32 patients showed three patterns: (1) decline to normal, associated with a disease-free state; (2) decline but not to normal, associated with heavy cigarette smoking or persistent disease; and (3) decline to normal, followed by a rise to abnormal, associated with tumor recurrence. Elevation of CEA levels preceded recognition of recurrent cervical cancer by as much as 4 months in five of seven patients.

摘要

对75例浸润性宫颈癌患者在放疗期间及放疗后测定了血浆癌胚抗原(CEA)水平。65%的患者初始CEA水平升高,其发生率随疾病分期而异。在治疗期间随访的32例患者中,26例(81%)CEA水平升高。同一32例患者治疗后的CEA值呈现三种模式:(1)降至正常,与无病状态相关;(2)下降但未降至正常,与大量吸烟或疾病持续存在相关;(3)降至正常,随后又升至异常,与肿瘤复发相关。在7例患者中的5例中,CEA水平升高比复发性宫颈癌的确诊早达4个月。

相似文献

1
Carcinoembryonic antigen in patients treated with radiation therapy for invasive squamous cell carcinoma of the uterine cervix.子宫颈浸润性鳞状细胞癌放射治疗患者的癌胚抗原
AJR Am J Roentgenol. 1976 Nov;127(5):829-31. doi: 10.2214/ajr.127.5.829.
2
[Serum CEA as a prognostic factor in patients with squamous cell carcinoma of the cervix treated by radiation].[血清癌胚抗原作为接受放疗的宫颈癌鳞状细胞癌患者的预后因素]
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Dec;36(12):2661-4.
3
[Carcinoembryonic antigen in carcinoma of the uterine cervix. Correlations with clinical stage, histopathology, and survival about 115 cases (author's transl)].
Pathol Biol (Paris). 1979 Dec;27(10):611-4.
4
Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.根治性放疗联合或不联合同期化疗治疗宫颈鳞癌患者,治疗前癌胚抗原的预后价值。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1105-13. doi: 10.1016/j.ijrobp.2010.07.011. Epub 2010 Oct 6.
5
[A case of immunohistochemically carcinoembryonic antigen producing cervical cancer--the evaluation of plasma CEA levels in 201 patients with uterine cancer].
Gan No Rinsho. 1987 Jul;33(8):975-80.
6
Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress.宫颈癌和外阴癌患者的癌胚抗原。血清水平与疾病进展。
Obstet Gynecol. 1976 Jan;47(1):95-9.
7
Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.肿瘤标志物癌胚抗原(CEA)、组织多肽抗原(TPA)和鳞状细胞癌抗原(SCC-Ag)在国际妇产科联盟(FIGO)低风险IB期和IIA期子宫颈鳞状细胞癌患者中的应用。
Gynecol Oncol. 2000 Jan;76(1):103-6. doi: 10.1006/gyno.1999.5665.
8
Localization of carcinoembryonic antigen in uterine cervical neoplasia.癌胚抗原在子宫颈肿瘤中的定位
Indian J Med Res. 1990 Dec;92:452-5.
9
Carcinoembryonic antigen levels in patients with squamous cell carcinoma of the cervix.子宫颈鳞状细胞癌患者的癌胚抗原水平。
Obstet Gynecol. 1978 May;51(5):536-40. doi: 10.1097/00006250-197805000-00004.
10
Carcinoembryonic antigen in carcinoma of the uterine cervix. 1. The prognostic value of serial plasma determinations.子宫颈癌中的癌胚抗原。1. 系列血浆测定的预后价值。
Cancer. 1978 Nov;42(5):2428-34. doi: 10.1002/1097-0142(197811)42:5<2428::aid-cncr2820420544>3.0.co;2-n.

引用本文的文献

1
Tumour lysis as a factor affecting blood levels of CEA.肿瘤溶解作为影响癌胚抗原血液水平的一个因素。
Br J Cancer. 1982 Aug;46(2):213-9. doi: 10.1038/bjc.1982.186.